BAI-BACE for advanced lung squamous cell carcinoma
Part of Cancer clinical trials.
This trial is testing a new use of a procedure called BAI-BACE (injecting drugs or blocking blood flow through the bronchial artery) for people with advanced lung squamous cell carcinoma that hasn't responded to prior treatments. The goal is to see if this treatment can help control the cancer when it's still only in the chest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell carcinoma (a type of lung cancer) that is located in the center of your chest.
- You are between 18 and 80 years old.
- You have already tried standard first-line or second-line treatment and it didn't work or you can't take it.
- Your cancer is only in your chest (not spread to other parts of the body).
- Your tumor's blood supply comes from the bronchial artery (confirmed by a special CT scan).
- You are in fairly good health (able to do light activities, ECOG score 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, BA1302, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if BA1302 is safe and effective.
This Phase 1 study tests BA1202 in people with advanced solid cancers to find safe dosing and how the treatment may work. You may qualify if your cancer has progressed or you cannot use standard treatment, and—depending on the group—your tumor shows a specific marker called CEACAM5.
This trial tests a new targeted drug (SHR-A1904) in people with advanced biliary tract cancer whose tumors have a specific protein (Claudin18.2) and who have already tried at least one standard treatment. The goal is to see if this drug can shrink the cancer or slow its growth.
This trial tests a new way to treat advanced non-small cell lung cancer by combining two targeted interventional procedures: one puts tiny beads with chemo directly into the tumor (DEB-BACE), and the other uses an artery to deliver treatment (BAI). The goal is to shrink the tumor and improve symptoms.
This trial tests a treatment called bronchial artery chemoembolization (BACE) combined with drug therapy for advanced non-small cell lung cancer. BACE delivers chemotherapy directly to the tumor through the blood vessel that feeds it, which may help control the cancer when standard treatments have stopped working.
This trial tests a combination of a new drug (D-BACE), chemotherapy, and carlizumab for people with a certain type and stage of lung cancer that can be removed with surgery. It aims to see if this combination helps shrink tumors and improves outcomes.
Hear when a new Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.